Clinical Trials
12 trialsNCT03256916 2026-02-24
NELCER
Tata Memorial Hospital
Phase 3 Completed
NCT03914443 2025-05-31
A Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal Carcinoma
National Cancer Center, Japan
Phase 1 Completed
NCT06358599 2024-04-10
The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy
Ankara Etlik City Hospital
Completed
NCT01003964 2022-04-12
Pharmacogenomic Study for Providing Personalized Strategy to the Treatment of Non-small Cell Lung Cancer (NSCLC) IIIB/IV
National Cancer Center, Korea
Phase 2 Completed
NCT02778308 2021-04-06
Adjuvant Chemotherapy vs no Chemotherapy for Patients With GallBllader Carcinoma
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research
Phase NA Completed
NCT03413436 2020-08-28
Lobaplation or Cisplatin in Adjuvant Chemotherapy for Esophageal Carcinoma
Henan Cancer Hospital
Phase 4 Completed
NCT02414685 2020-08-07
TIP
National Cancer Institute, Slovakia
Phase 2 Completed
NCT02095119 2015-04-14
A Monoclonal Antibody, Nimotuzumab, as Treatment for Recurrent or Metastatic Cervical Cancer
National Institute of Cancerología
Phase 1/2 Completed
NCT00697905 2014-11-21
Combination of Gemcitabine and Carboplatin in Metastatic or Recurrent Nasopharyngeal Carcinoma
Ministry of Health, Malaysia
Phase 2 Completed
NCT00452634 2013-06-19
Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)
National Cancer Center, Korea
Phase 2 Completed
NCT00122772 2011-10-14
CRP on Radiobiological and Clinical Studies on Viral-Induced Cancer's Response to Radiotherapy
International Atomic Energy Agency
Phase 3 Completed
NCT00686322 2011-09-15
Concurrent Chemoradiotherapy (CCRT) With Paclitaxel Plus Cisplatin in LA Non-small-cell Lung Cancer (NSCLC)
Taipei Veterans General Hospital, Taiwan
Phase 4 Completed